Lamellar sliver: devastating complication of recutting after LASIK

Article

A lamellar sliver is a devastating complication resulting from recutting flaps during LASIK enhancement procedures.

A lamellar sliver is a devastating complication resulting from recutting flaps during LASIK enhancement procedures, said Jonathan Song, MD, from the Doheny Eye Institute, Los Angeles, US.

Retreatment, he noted, is needed in 3–10% of patients who undergo LASIK. After LASIK was initially introduced, recutting was advised after six months; later, relifting was advised after one year and then after two years. However, a serious complication, lamellar sliver, which is tissue missing from the flap as a result of recutting, was reported to have caused irregular astigmatism and decreased visual acuity. Twelve patients were found to have this complication after procedures performed by nine experienced surgeons; all patients had irregular astigmatism, significant loss of best-corrected visual acuity, and very high subjective visual difficulties.

To prevent the lamellar sliver, Dr Song advised surgeons to relift all flaps if possible - relifting can be done up to 10 years using a needle or a depression technique.

“The technique that I prefer in patients with a relatively new flap is where the edge of the flap can be depressed and a blunt instrument used to go inside the edge,” he said. “A spatula can be used to loosen any adhesion.”

After retreatment, the edges should be clean and any loose epithelium removed. A bandage contact lens can be considered. If the flap is difficult to lift, he suggested converting to surface ablation with mitomycin C.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.